PHAT icon

Phathom Pharmaceuticals

87 hedge funds and large institutions have $317M invested in Phathom Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less capital invested

Capital invested by funds: $ → $

7% less funds holding

Funds holding: 9487 (-7)

9.25% less ownership

Funds ownership: 77.04%67.79% (-9.3%)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

Holders
87
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$133K
Puts
$124K
Net Calls
Net Calls Change

Top Buyers

1 +$4.68M
2 +$1.89M
3 +$1.7M
4
Walleye Capital
Walleye Capital
New York
+$1.64M
5
Invesco
Invesco
Georgia
+$1.57M

Top Sellers

1 -$26.8M
2 -$3.52M
3 -$1.71M
4
HF
HRT Financial
New York
-$585K
5
Millennium Management
Millennium Management
New York
-$558K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$94.3M
2
$27.9M
3
$24.8M
4
$21.3M
5
$19.8M
6
$19M
7
$16.1M
8
$15.1M
9
$12.1M
10
$6.67M
11
$6.19M
12
$5.43M
13
$5.06M
14
$4.88M
15
$4.74M
16
$4.68M
17
$2.76M
18
$2.64M
19
$2.37M
20
$2.2M
21
$1.94M
22
$1.64M
23
$1.45M
24
$1.21M
25
$1.1M